Atorvastatin Calcium
NDC Package 63304-830-05

11-digit billing NDC: 63304083005 · Billing unit: EA · 500 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Atorvastatin Calcium is therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Marketed by Sun Pharmaceutical Industries Inc., this product is identified by NDC 63304-830 and is authorized under FDA application ANDA076477.

Identification & Billing

NDC Package Code
63304-830-05
Package Description
500 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
63304083005
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
500 EA

Clinical Specifications

Proprietary Name
Atorvastatin Calcium
Dosage Form
-
Usage Information
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. In patients with CHD or multiple risk factors for CHD, atorvastatin calcium tablets can be started simultaneously with diet.

Regulatory & Marketing

Labeler Name
Sun Pharmaceutical Industries Inc.
FDA Application #
ANDA076477
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2011
End Marketing Date
03-31-2025
Listing Expiration
03-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63304-830). Click a package code to view its specific billing and regulatory data.

90 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63304-830-05 identifies a specific commercial package of 500 tablet, film coated in 1 bottle of Atorvastatin Calcium, labeled by Sun Pharmaceutical Industries Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries Inc. on December 01, 2011. The current certification is valid through March 31, 2025.

How is this Sun Pharmaceutical Industries Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63304083005. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63304-830-05
11-Digit CMS (5-4-2)
63304-0830-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.